Active ingredientSimeprevirCat. No. P-S044-001CAS 923604-59-5Family · Pharmaceutical analytical standards
Simeprevir
An NS3/4A protease inhibitor of the hepatitis C virus, approved in the United States in 2013 for chronic genotype 1 hepatitis C, to be used in combination with other antivirals. This family brings together the active ingredient and labelled standards.
Did you know?It has also been studied against SARS-CoV-2: in the laboratory it can inhibit both the main protease and the RNA polymerase of the COVID-19 virus.
Go to the active ingredient →Active ingredientSimeprevirCat. No. P-S044-001CAS 923604-59-5
Isotopically labelledSimeprevir-13C-d3Cat. No. P-S044-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.